Senile systemic amyloidosis: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
||
Line 22: | Line 22: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Amyloidosis}} | {{Amyloidosis}} |
Latest revision as of 14:53, 6 September 2012
Senile systemic amyloidosis | |
ICD-9 | 277.3 |
---|---|
OMIM | 176300 |
eMedicine | med/3365 |
Senile systemic amyloidosis is a form of amyloidosis associated with transthyretin.[1]
It is estimated to affect a quarter of the population over 85 years of age.[2]
References
- ↑ Westermark P, Sletten K, Johansson B, Cornwell GG (1990). "Fibril in senile systemic amyloidosis is derived from normal transthyretin". Proc. Natl. Acad. Sci. U.S.A. 87 (7): 2843–5. PMC 53787. PMID 2320592. Unknown parameter
|month=
ignored (help) - ↑ Tanskanen M, Peuralinna T, Polvikoski T; et al. (2008). "Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study". Ann. Med. 40 (3): 232–9. doi:10.1080/07853890701842988. PMID 18382889. Text "1B69BA326FFE69C3F0A8F227DF8201D0" ignored (help)
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Senile systemic amyloidosis On the Web |
American Roentgen Ray Society Images of Senile systemic amyloidosis |
Risk calculators and risk factors for Senile systemic amyloidosis |